Rheumatoid arthritis is the most common autoimmune disease of the joints. It causes a chronic inflammatory response, with the body’s own immune cells attacking the joint, including the cartilage and bone. This process does not cease spontaneously. Medical researchers have now managed to identify an immune system cell type that can be used in a targeted attempt to control the inflammatory response in arthritis patients.
